BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33419826)

  • 1. Impact of Insulin Treatment on Prognosis of non-B non-C Hepatocellular Carcinoma After Hepatectomy.
    Amemiya H; Matsuda M; Saito R; Hosomura N; Kawaida H; Kono H; Akaike H; Kawaguchi Y; Sudo M; Ichikawa D
    Anticancer Res; 2021 Jan; 41(1):317-326. PubMed ID: 33419826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Features and Outcome of Surgical Patients with Non-B Non-C Hepatocellular Carcinoma.
    Wakiyama S; Matsumoto M; Haruki K; Gocho T; Sakamoto T; Shiba H; Futagawa Y; Ishida Y; Yanaga K
    Anticancer Res; 2017 Jun; 37(6):3207-3213. PubMed ID: 28551666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
    Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
    J Surg Oncol; 2014 Dec; 110(8):976-81. PubMed ID: 25171344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma.
    Wu SS; Shan QY; Xie WX; Chen B; Huang Y; Guo Y; Xie XY; Lu MD; Peng BG; Kuang M; Shen SL; Wang W
    Clin Transl Oncol; 2020 Mar; 22(3):401-410. PubMed ID: 31172445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Hepatic Steatosis on Disease-Free Survival in Patients with Non-B Non-C Hepatocellular Carcinoma Undergoing Hepatic Resection.
    Nishio T; Hatano E; Sakurai T; Taura K; Okuno M; Kasai Y; Seo S; Yasuchika K; Mori A; Kaido T; Uemoto S
    Ann Surg Oncol; 2015 Jul; 22(7):2226-34. PubMed ID: 25395147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients.
    Utsunomiya T; Shimada M; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Takayama T; Kokudo N;
    Ann Surg; 2015 Mar; 261(3):513-20. PubMed ID: 25072437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
    Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of hepatectomy for patients with non-hepatitis B, non-hepatitis C hepatocellular carcinoma.
    Ochiai T; Ogino S; Ishimoto T; Toma A; Yamamoto Y; Morimura R; Ikoma H; Otsuji E
    Anticancer Res; 2014 Aug; 34(8):4399-410. PubMed ID: 25075077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
    Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
    Yokoi Y; Suzuki S; Baba S; Inaba K; Konno H; Nakamura S
    J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy.
    Wang YY; Huang S; Zhong JH; Ke Y; Guo Z; Liu JQ; Ma L; Li H; Ou BN; Li LQ
    PLoS One; 2014; 9(12):e113858. PubMed ID: 25436613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral serostatus and coexisting inflammatory activity affect metachronous carcinogenesis after hepatectomy for hepatocellular carcinoma. A further report.
    Yamanaka N; Takada M; Tanaka T; Yamanaka J; Yasui C; Ando T; Maeda S; Matsushita K; Okamoto E
    J Gastroenterol; 2000; 35(3):206-13. PubMed ID: 10755690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and prognosis of non-B, non-C hepatocellular carcinoma: The impact of patient sex on disease-free survival - A retrospective cohort study.
    Hashimoto M; Tashiro H; Kobayashi T; Kuroda S; Hamaoka M; Ohdan H
    Int J Surg; 2017 Mar; 39():206-213. PubMed ID: 28159713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinicopathologic characteristics among patients with HBV-positive, HCV-positive and Non-B Non-C hepatocellular carcinoma after hepatectomy: a systematic review and meta-analysis.
    Yu B; Zhi X; Li Q; Li T; Chen Z
    BMC Gastroenterol; 2023 Aug; 23(1):289. PubMed ID: 37612653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection.
    Li T; Qin LX; Gong X; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Fan J
    Cancer; 2013 Jan; 119(1):126-35. PubMed ID: 22736338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic nomogram for patients with non-B non-C hepatocellular carcinoma after curative liver resection.
    Zhang W; Tan Y; Jiang L; Yan L; Yang J; Li B; Wen T; Wu H; Wang W; Xu M
    Int J Surg; 2017 Aug; 44():160-165. PubMed ID: 28629767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical Outcomes of Hepatic Resection for Hepatitis B Virus Surface Antigen-Negative and Hepatitis C Virus Antibody-Negative Hepatocellular Carcinoma.
    Yamashita Y; Imai D; Bekki Y; Kimura K; Matsumoto Y; Nakagawara H; Ikegami T; Yoshizumi T; Shirabe K; Aishima S; Maehara Y
    Ann Surg Oncol; 2015 Jul; 22(7):2279-85. PubMed ID: 25472646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic Features and Outcomes of Non-B, Non-C Hepatocellular Carcinoma After Hepatectomy.
    Takeishi K; Maeda T; Shirabe K; Tsujita E; Yamashita Y; Harimoto N; Itoh S; Ikegami T; Yoshizumi T; Maehara Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1116-24. PubMed ID: 26159442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of the Hepatitis B Core Antibody Status on Recurrence in Patients with Non-B Non-C Hepatocellular Carcinoma after Curative Surgery.
    Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
    Dig Surg; 2018; 35(3):243-251. PubMed ID: 28810252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological factors affecting survival and recurrence after initial hepatectomy in non-B non-C hepatocellular carcinoma patients with comparison to hepatitis B or C virus.
    Okuda Y; Mizuno S; Shiraishi T; Murata Y; Tanemura A; Azumi Y; Kuriyama N; Kishiwada M; Usui M; Sakurai H; Tabata M; Yamada T; Isaji S
    Biomed Res Int; 2014; 2014():975380. PubMed ID: 24745029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.